Corporate News     07-Feb-12
Orchid Chemicals & Pharmaceuticals receives USFDA approval
For Levofloxacin tablets
Orchid Chemicals & Pharmaceuticals has received approval from the USFDA for its ANDA (Abbreviated New Drug Application) for Levofloxacin tablets in strengths of 250 mg, 500 mg and 750 mg.
Previous News
  Orchid Pharma reports consolidated net profit of Rs 19.80 crore in the September 2023 quarter
 ( Results - Announcements 06-Nov-23   07:34 )
  Maral Overseas Ltd leads gainers in 'B' group
 ( Hot Pursuit - 30-Jan-24   12:15 )
  Orchid Pharma hits 52-week high on receiving EMA nod for Exblifep
 ( Hot Pursuit - 30-Jan-24   12:55 )
  Orchid Pharma Ltd leads losers in 'B' group
 ( Hot Pursuit - 24-Jun-21   14:45 )
  Orchid Pharma to conduct AGM
 ( Corporate News - 24-Jul-21   15:09 )
  Orchid Pharma to hold AGM
 ( Corporate News - 07-Dec-20   12:03 )
  Orchid Pharma schedules AGM
 ( Corporate News - 23-Nov-18   09:52 )
  Orchid Pharma to declare Quarterly Result
 ( Corporate News - 08-Aug-23   16:04 )
  Orchid Pharma to hold AGM
 ( Corporate News - 16-Dec-19   15:57 )
  Orchid Pharma schedules board meeting
 ( Corporate News - 08-Feb-19   10:09 )
  Orchid Chemicals & Pharmaceuticals net profit declines 28.09% in the June 2011 quarter
 ( Results - Announcements 29-Jul-11   10:53 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top